Sagimet Biosciences Inc [NASDAQ: SGMT] jumped around 0.04 points on Friday, while shares priced at $3.45 at the close of the session, up 1.17%.
Compared to the average trading volume of 497.96K shares, SGMT reached a trading volume of 117442 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sagimet Biosciences Inc [SGMT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SGMT shares is $26.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SGMT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Sagimet Biosciences Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on December 06, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Buy. The new note on the price target was released on November 12, 2024, representing the official price target for Sagimet Biosciences Inc stock. Previously, the target price had yet another drop from $23 to $6, while Goldman kept a Neutral rating on SGMT stock.
The Average True Range (ATR) for Sagimet Biosciences Inc is set at 0.28 The Price to Book ratio for the last quarter was 0.80, with the Price to Cash per share for the same quarter was set at 4.71.
How has SGMT stock performed recently?
Sagimet Biosciences Inc [SGMT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.14. With this latest performance, SGMT shares gained by 10.58% in over the last four-week period, additionally sinking by -21.77% over the last 6 months – not to mention a drop of -27.97% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SGMT stock in for the last two-week period is set at 55.61, with the RSI for the last a single of trading hit 57.42, and the three-weeks RSI is set at 53.52 for Sagimet Biosciences Inc [SGMT]. The present Moving Average for the last 50 days of trading for this stock 3.13, while it was recorded at 3.39 for the last single week of trading, and 4.00 for the last 200 days.
Sagimet Biosciences Inc [SGMT]: Deeper insight into the fundamentals
Sagimet Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 20.26 and a Current Ratio set at 20.26.
Insider trade positions for Sagimet Biosciences Inc [SGMT]
There are presently around $45.73%, or 49.92%% of SGMT stock, in the hands of institutional investors. The top three institutional holders of SGMT stocks are: POINT72 ASSET MANAGEMENT, L.P. with ownership of 2.37 million shares, which is approximately 7.414%. NEA MANAGEMENT COMPANY, LLC, holding 2.0 million shares of the stock with an approximate value of $$6.84 million in SGMT stocks shares; and NEA MANAGEMENT COMPANY, LLC, currently with $$5.72 million in SGMT stock with ownership which is approximately 5.245%.
